Stock(600222)Hot line:010-61006450

About Us


Leadingpharm was founded in 2005. It is the first company listed on the main board in China (Stock Code: 600222), aiming to promote the development of China's pharmaceutical industry with innovative modes of research, development and service, as well as information technology. Based on the international perspective, Leadingpharm has formed its core competitive advantages, which are internationalization, integration and industrialization. With the mature and perfect drug R & D management system, rich project experience and the team of thousands of senior experts at home and abroad, Leadingpharm has formed a CXO Service System covering the whole industry chain including preclinical research, clinical CRO, CDMO and MAH entrusted quality management, and realized the full coverage of innovative drugs, high-end complex preparations, cell gene therapy drugs and other fields, which can provide real one-stop service for global customers.





  • Company News

Alumni Exchange | Alumni of China Europe International Business School (CEIBS) Came to Leadingpharm and Decrypted the Pharmaceutical R & D Enterprise

On February 25, the first stop of the 2022 "Together with You" series of study tour activities initiated by the Alumni Relations Office of CEIBS Beijing Campus, "Decrypting Pharmaceutical R & D Enterprises - Entering Leadingpharm Pharmaceutical Technology", was successfully held in Beijing.


A Warm Chinese New Year and A Smooth Way Home – Leadingpharm’s Heartwarming Measures Makes the New Year More Festive

The Spring Festival is approaching, Leadingpharm also has strong festival atmosphere. Facing with the severe and complex situation of COVID-19 prevention and control, whether to "go home" or "celebrate the new year locally" has become a question for every member in Leadingpharm. In this regard, Leadingpharm launched a series of warm-hearted measures for employees who celebrate the new year locally, and provide convenience for employees who return home.